{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:18:32Z","timestamp":1785766712296,"version":"3.56.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metastasis in adrenocortical carcinoma (ACC) presents a formidable clinical challenge, with limited insights into its underlying mechanisms and few effective treatment options. This study aimed to identify molecular markers associated with metastasis in adult ACC and to explore novel therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA sequencing data from 74 adult ACC patients were analyzed using bioinformatics approaches, including weighted gene co-expression network analysis (WGCNA) and differential gene expression analysis. Functional pathway enrichment analyses were conducted to identify metastasis-associated genes and to explore key biological pathways contributing to metastatic progression. Candidate genes were selected based on their statistical significance, prognostic relevance, and involvement in metastatic processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven hub genes were identified as significantly associated with metastasis and poor prognosis in ACC patients. These genes were enriched in pathways critical to tumor progression, such as mismatch repair, nucleotide excision repair, and cell cycle regulation. High expression levels of these genes correlated with reduced overall survival. Importantly, potential therapeutic agents targeting these molecular drivers were identified, offering promising, lower-toxicity options for treating metastatic ACC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The molecular markers identified in this study offer valuable insights into the mechanisms underlying ACC metastasis and represent promising therapeutic targets, providing a foundation for developing improved treatment strategies in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1516467","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:23:53Z","timestamp":1761801833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Innovative molecular targets for combatting metastasis in adrenocortical carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Jianqiu","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuogui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2291","article-title":"Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0452","article-title":"Future directions in the diagnosis and medical treatment of adrenocortical carcinoma","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocrine-related Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0426-0","article-title":"A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study","volume":"39","author":"Kong","year":"2019","journal-title":"Cancer Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Libe","year":"2015","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","article-title":"Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors","volume":"9","author":"Gara","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40425-018-0424-9","article-title":"Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial","volume":"6","author":"Le Tourneau","year":"2018","journal-title":"J immunother cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01624","article-title":"Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors","volume":"102","author":"Henning","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1118","article-title":"ENDOCRINE TUMOURS: The genomics of adrenocortical tumors","volume":"174","author":"Faillot","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.54","article-title":"P53\/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model","volume":"36","author":"Batisse-Lignier","year":"2017","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/cancers10080273","article-title":"Functional linkage of RKIP to the epithelial to mesenchymal transition and autophagy during the development of prostate cancer","volume":"10","author":"Ahmed","year":"2018","journal-title":"Cancers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"693-700","DOI":"10.3892\/mmr.2019.10295","article-title":"Identification of specific modules and significant genes associated with colon cancer by weighted gene coexpression network analysis","volume":"20","author":"Feng","year":"2019","journal-title":"Mol Med Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31922","article-title":"Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma\/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy","volume":"144","author":"Subramanian","year":"2019","journal-title":"Int J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4402565\/v1","article-title":"Single-cell transcriptomics reveals stage- and side-specificity of gene modules in colorectal cancer","volume":"24","author":"Rahiminejad","year":"2024","journal-title":"Res Sq"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.3.5526","article-title":"Comparative genomic hybridization analysis of adrenocortical tumors of childhood","volume":"84","author":"Figueiredo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199809010-00103","article-title":"DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas","volume":"10","author":"Iino","year":"1997","journal-title":"Mod Pathol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01249-6","article-title":"Systemic management of advanced adrenocortical carcinoma","volume":"25","author":"Russell","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41598-018-38017-0","article-title":"FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression","volume":"9","author":"Varghese","year":"2019","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-018-0906-0","article-title":"miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFbeta pathway","volume":"37","author":"Wang","year":"2018","journal-title":"J Exp Clin Cancer research: CR"},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12935-019-0764-7","article-title":"Roles of beta-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance","volume":"19","author":"Jin","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5451290","DOI":"10.1155\/2019\/5451290","article-title":"Prognostic value of BIRC5 in lung adenocarcinoma lacking EGFR, KRAS, and ALK mutations by integrated bioinformatics analysis","volume":"2019","author":"Cao","year":"2019","journal-title":"Dis Markers."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9598","article-title":"Exploration of the diagnostic value and molecular mechanism of miR\u22121 in prostate cancer: A study based on meta\u2212analyses and bioinformatics","volume":"18","author":"Xie","year":"2018","journal-title":"Mol Med Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1533033818794190","DOI":"10.1177\/1533033818794190","article-title":"Decreased expression of ZWINT is associated with poor prognosis in patients with HCC after surgery","volume":"17","author":"Yang","year":"2018","journal-title":"Technol Cancer Res Treat."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S200907","article-title":"Sp1 contributes to radioresistance of cervical cancer through targeting G2\/M cell cycle checkpoint CDK1","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0861-z","article-title":"KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner","volume":"38","author":"Qian","year":"2019","journal-title":"Oncogene."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1038\/s41598-019-45571-8","article-title":"CDK inhibitors reduce cell proliferation and reverse hypoxia-induced metastasis of neuroblastoma tumours in a chick embryo model","volume":"9","author":"Swadi","year":"2019","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41065-019-0096-6","article-title":"Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico","volume":"156","author":"Cai","year":"2019","journal-title":"Hereditas."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S174355","article-title":"A novel SWIM domain protein ZSWIM5 inhibits the Malignant progression of non-small-cell lung cancer","volume":"10","author":"Xu","year":"2018","journal-title":"Cancer Manag Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101830","article-title":"The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1","volume":"11","author":"Guo","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-018-0157-x","article-title":"The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance","volume":"99","author":"Fei","year":"2019","journal-title":"Lab Invest."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8973","article-title":"Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer","volume":"16","author":"Shan","year":"2018","journal-title":"Oncol Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12094-018-1906-4","article-title":"Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma","volume":"21","author":"Deng","year":"2019","journal-title":"Clin Transl Oncol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192316","article-title":"XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer","volume":"13","author":"He","year":"2018","journal-title":"PLoS One."},{"key":"B44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-019-1297-6","article-title":"CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis","volume":"38","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10130","article-title":"Identification of key genes involved in the metastasis of clear cell renal cell carcinoma","volume":"17","author":"Wei","year":"2019","journal-title":"Oncol Lett."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-15-2256","article-title":"Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma","volume":"22","author":"Satoh","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-2636","article-title":"Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer","volume":"79","author":"Shinde","year":"2019","journal-title":"Cancer Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1516467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:23:54Z","timestamp":1761801834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1516467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1516467"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1516467","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"1516467"}}